Browsing Tag

Shareholders

Sanofi to buy Synthorx for $2.5 billion

France’s Sanofi said on Monday it had agreed to buy Synthorx in a cash deal worth around $2.5 billion as it seeks to beef up its immuno-oncology pipeline. Under the terms of the merger agreement, Sanofi has offered to buy all of the

Advertisement

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More